Relaxation abnormalities. Part II: Clinical aspects.
D000818:Animals; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002118:Calcium / Q000378:metabolism; D006332:Cardiomegaly / Q000175:diagnosis; D002312:Cardiomyopathy, Hypertrophic / Q000175:diagnosis; D002316:Cardiotonic Agents / Q000627:therapeutic use; D003327:Coronary Disease / Q000175:diagnosis; D004232:Diuretics / Q000627:therapeutic use; D006333:Heart Failure / Q000175:diagnosis* / Q000188:drug therapy; D006801:Humans; D006973:Hypertension / Q000175:diagnosis; D007473:Ion Channels / Q000502:physiology; D009200:Myocardial Contraction; D013318:Stroke Volume
D000959:Antihypertensive Agents; D002316:Cardiotonic Agents; D004232:Diuretics; D007473:Ion Channels; D002118:Calcium